Abstract
Objective To report the relationship of Outpatient Patient Portal (OPP) use with clinical risk, area social determinants of health (SDoH), and race/ethnicity among pregnant women.
Methods Regression models predicting overall and individual portal feature use (main effects and interactions) based on key variables were specified using logfiles and clinical data.
Results Overall OPP use among non-Hispanic Black women or patients who lived in lower SDoH neighborhoods were significantly less. High-risk pregnancy patients were likely to use the OPP more than those with normal-risk pregnancy. We found similar associations with individual OPP features, like the Visit (scheduling) and My Record (test results). We also found significant interactive associations between race, clinical risk, and SDoH. Non-Hispanic Black women living in lower SDoH areas used OPP less than non-Hispanic White women from similar or affluent areas.
Conclusion More research must be conducted to learn of OPP implications for pregnant women with specific clinical diagnoses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Retrospective data were obtained for patient encounters from our AMC's Information Warehouse (IW) in accordance with the Honest Broker protocol. This protocol is recognized by the Ohio State University Institutional Review Board (IRB) as a means to use de-identified data without requiring formal IRB approval. Approved data request number: REQ674151 Details about the Honest Broker protocol: https://u.osu.edu/researchdatarequest/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: Priti.Singh{at}osumc.edu
Email: Pallavi.Jonnalagadda{at}osumc.edu
Email: Evan.Morgan{at}osumc.edu
460 Medical Center Drive, Columbus, OH 43210, United States, Phone: 614-366-0283, Email: Naleef.Fareed{at}osumc.edu
Disclosure Statement: All authors declare no commercial associations or conflicts of interest
Funding Details: None
Data Availability
Data is restricted for this study.
